Following Tamoxifen With Aromatase Inhibitor May Improve Survival in Early Breast Cancer
WESTPORT, CT (Reuters Health) Nov 29 – In postmenopausal women with early breast cancer, switching from tamoxifen to aminoglutethimide after 3 years of adjuvant treatment





